Exicure, Inc. XCUR
0.96 USD -0.05 (-4.94%)
Nov 4, 2026, 10:54 AM EST
0.95 Day range 1.00
0.875 52-week range 9.48
- YTD
- -82.29%
- 1 year
- -77.30%
- Market cap
- 6.28M
- Revenue (ttm)
- 500.00K
- EPS (ttm)
- -1.30
- Shares out
- 3.04M
- Forward P/E
- -25.38
- YTD return
- -82.29%
- 1-year return
- -77.30%
- Volume
- 7.39K
- Avg volume
- 44.28K
- Open
- 0.97
- Previous close
- 1.01
- Day's range
- 0.95 – 1.00
- 52-week range
- 0.875 – 9.48
- Beta
- 1.28
- Earnings date
- May 16, 2024
2Y -2.0000 (-67.57%)
Key statistics
- Enterprise value
- 11.80M
- PEG ratio
- 0.00
- Price / sales
- 118.77
- Price / book
- 11.15
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -2.03M
- Total cash
- 528.00K
- Total debt
- 7.32M
- Return on equity
- -144.41%
- Short % of float
- 1.99%
- 50-day average
- 10.48
- 200-day average
- 4.42
Next earnings
May 16, 2024
Expected May 16, 2024. Consensus EPS estimate 0.00.
Financials — quick view
XCUR Revenue — quarterly 0
XCUR Net income — quarterly -1.12M
XCUR EPS — quarterly -0.18
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 13, 2024 | Jun 1, 2024 | 0.00 | -0.35 | — | — |
| Jun 17, 2024 | Mar 1, 2024 | 0.00 | -0.50 | — | — |
| Jun 6, 2024 | Dec 1, 2023 | 0.00 | -0.65 | — | — |
| May 16, 2024 | Sep 1, 2023 | 0.00 | — | — | — |
| Aug 11, 2023 | Jun 1, 2023 | 0.00 | -3.40 | — | — |
| Jul 14, 2023 | Mar 1, 2023 | 0.00 | -3.50 | — | — |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 16, 2022 | Chardan Capital | main | — | Neutral |
About Exicure, Inc.
Exicure, Inc. does not have significant operations. previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- exicuretx.com
News
12 Health Care Stocks Moving In Thursday's After-Market Session 
Comparing Shattuck Labs (NASDAQ:STTK) & Exicure (NASDAQ:XCUR) 
12 Health Care Stocks Moving In Thursday's After-Market Session 
Exicure Receives Nasdaq Extension Through December 2 To Regain Compliance 
Exicure Receives Nasdaq Extension to Regain Compliance with Stockholders' Equity Requirement 
12 Health Care Stocks Moving In Friday's Intraday Session - 12 Health Care Stocks Moving In Monday's After-Market Session
- Exicure Plans To Issue 172,058 Common Shares To GPCR Therapeutics During This Month To Settle $1M Clinical Milestone Payment Obligation
Exicure to Settle GPCR Therapeutics Clinical Milestone Payment Through Equity Issuance 
12 Health Care Stocks Moving In Monday's Intraday Session
Your note
Sign in to keep a note on XCUR — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CBI USA, INC. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Dec 14, 2022 | 4,218,300 |
| DGP CO., LTD. | Beneficial Owner of more than 10% of a Class of Security | Sale | Feb 28, 2024 | 0 |
| FELTNER DOUGLAS E | Officer | Stock Award(Grant) | Nov 14, 2021 | 15,000 |
| GATES VENTURES, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Sale | Dec 20, 2021 | 5,064,700 |
| GILJOHANN DAVID A. | Chief Executive Officer | Stock Award(Grant) | Nov 14, 2021 | 38,666 |
| MIRKIN CHAD A | Director and Beneficial Owner of more than 10% of a Class of Security | Sale | Jun 11, 2020 | 0 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Carlyle Group Inc. | 2.16% | 56,328 | 1.10M | Sep 29, 2024 |
| HRT Financial LP | 0.56% | 14,480 | 282.94K | Sep 29, 2024 |
| Northwestern University | 0.40% | 10,430 | 203.80K | Sep 29, 2024 |
| UBS Group AG | 0.37% | 9,588 | 187.35K | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.05% | 1,414 | 27.63K | Sep 29, 2024 |
| Morgan Stanley | 0.02% | 645 | 12.60K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Extended Market Index Fund | 0.31% | 8,019 | 156.69K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.16% | 4,167 | 81.42K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.06% | 1,527 | 29.84K | Oct 30, 2024 |
| Fidelity Total Market Index Fund | 0.03% | 896 | 17.51K | Oct 30, 2024 |
| Master Investment Portfolio-Diversified Equity Master Portfolio | 0.00% | 35 | 683 | Sep 29, 2024 |